Purify designer cytokine receptors for combat cytokine storm in severely infected COVID-19 patients
Our research is directly relevant to combat cytokine storm that is in severely COVID-19 infected patients. My lab including Dr. Rui Qing and Visiting Scholar Dr. Shilei Hao needs to produce and purify more the antibody-like receptor proteins to sop up cytokines for treating severely infected COVID-19 patients.
Please see the MIT News press release for our current research to possibly treat COVID-19 patients who experience cytokine storm.
Proteins may halt the severe cytokine storms seen in Covid-19 patients Team designs antibody-like receptor proteins that can bind to cytokines, as possible strategy for treating coronavirus and other infections. Day and duration of campus access, April 27-May 31, 10am-6pm.